Matthew R. Henn, See Remarks at Seres Therapeutics, Inc. (MCRB), sold 183,624 shares at $28.34 ($5.0M) on 2020-12-01, disclosed to the SEC on 2020-12-03.
Open-market sale of $5.0M MCRB by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.56 | 55,706 | $1.5M | 29.8% |
| 2 | $26.56 | 55,706 | $1.5M | 29.8% |
| 3 | $27.56 | 26,265 | $724K | 14.6% |
| 4 | $27.56 | 26,265 | $724K | 14.6% |
| 5 | $28.34 | 9,841 | $279K | 5.6% |
| 6 | $28.34 | 9,841 |
| $279K |
| 5.6% |
| Total | $27.04 avg | 183,624 | $5.0M | 100% |
| Filing → |
| MCRB | SELL | 2024-10-29 | $3K | — | Filing → |
| MCRB | SELL | 2024-08-19 | $775 | — | Filing → |
| MCRB | SELL | 2024-05-17 | $838 | — | Filing → |